Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Schrodinger Inc (NQ: SDGR )

22.68 -0.46 (-1.99%)
Streaming Delayed Price Updated: 2:43 PM EDT, May 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Schrodinger Inc

< Previous 1 2 3 4 5 6 7 Next >
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion. 
Via Benzinga
7 Small-Cap Stock Picks to Beat the September Market Slump
With the macro environment not as dreary as the bears believe, investors should consider buying one or more of my small-cap stock picks. 
Via InvestorPlace
Cathie Wood Loads Up $4.6M In Bill Gates-Backed Healthcare Tech Company
Cathie Wood-led Ark Investment Management on Thursday bought 162,276 shares of Schrodinger Inc (NASDAQ: SDGR) through the Ark Genomic Revolution ETF (BATS: ARKG), trading d 
Via Benzinga
Gain Therapeutics: Reasons For Optimism
In biotechnology, potential rules. And in Gain's case, the potential to not just treat but functionally cure at least some forms of Parkinson's Disease is strong enough to weather early-stage... 
Via Talk Markets
3 Biotech Stocks to Buy on the Dip
Biotech stocks have rebounded lately and are poised to keep surging, so it's a good time to buy biotech stocks on the dip. 
Via InvestorPlace
The 7 Best Stocks to Buy on a Dip in July
With the stock market pricing in a recession that likely won't arrive anytime soon, these are some of the best stocks to buy on a dip. 
Via InvestorPlace
Schrodinger: Q4 Earnings Insights
Schrodinger (NASDAQ:SDGR) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Preview: Schrodinger's Earnings
Schrodinger (NASDAQ:SDGR) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
Why Jim Cramer Recommends Selling AGNC Investment
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Schrodinger Inc (NYSE: 
Via Benzinga
Schrödinger's Initial-Stage Cancer Study Gains FDA Clearance
Schrödinger Inc. (NASDAQ: SDGR) announced that the U.S. Food and Drug Administration (FDA) cleared its investigational new drug (IND) application for the drug candidate SGR-1505 in patients with... 
Via Benzinga
Bill Gates Stocks: 7 Top Picks From the Gates Foundation Portfolio
These Bill Gates stocks are great picks to buy now. BRK-B, CNI, DE, ECL, MSFT, SDGR, and WM can make excellent long-term investments. 
Via InvestorPlace
Recap: Schrodinger Q1 Earnings
Schrodinger (NASDAQ:SDGR) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Schrodinger beat estimated earnings... 
Via Benzinga
AI Pharma Startup METiS Raises $150 Million. IPO In Sight?
Key takeaways: METiS Pharmaceuticals has completed five funding rounds since its establishment in January 2020, including the latest two worth $150 million The company was... 
Via Benzinga
Schrödinger New Preclinical Data Supports Development Of Its Wee1 Inhibitor In Cancer Indications
Schrödinger Inc (NASDAQ: SDGR)  
Via Benzinga
The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Expert Ratings For Schrodinger
Over the past 3 months, 5 analysts have published their opinion on Schrodinger (NASDAQ: 
Via Benzinga
3 Hypergrowth Tech Stocks to Buy for Huge Upside Potential
These hypergrowth stocks are bargains after retreating for much of the last year. They will all perform very well for long-term investors. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022
Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ:RVMD) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71,... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Aerie Pharmaceuticals (NASDAQ:AERI) shares increased by 28.1% to $7.56 during Friday's regular session. Trading volume for Aerie Pharmaceuticals's stock is... 
Via Benzinga
93 Biggest Movers From Friday
Gainers Inspirato Incorporated (NASDAQ: ISPO) shares surged 50.5% to close at $54.90. Guardforce AI Co., Limited (NASDAQ: GFAI) jumped 45.4% to settle at $0.5979 on Friday. EF... 
Via Benzinga
45 Stocks Moving In Friday's Mid-Day Session
Gainers KAR Auction Services, Inc. (NYSE: KAR) shares climbed 39.2% to $19.05 after the company agreed to sell its ADESA U.S. physical auction business to Carvana for $2.2... 
Via Benzinga
3 Desirable Drug Stocks With Very Promising Pipelines
Drug makers with superb pipelines are likely to deliver great returns for long-term investors. Here are three drug stocks to consider. 
Via InvestorPlace
3 Stocks That Can Make You Rich in Just a Few Years
Investing in the most popular stocks on the Street won't make investors rich in a few years. To accomplish that goal, a contrarian spirit is needed. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
Upgrades Morgan Stanley upgraded the previous rating for EQT Corp (NYSE: 
Via Benzinga
91 Biggest Movers From Yesterday
Gainers NuZee, Inc. (NASDAQ: NUZE) shares jumped 164.5% to settle at $5.29 on Thursday. NuZee manufacturing partner, Cuvee Coffee, reported an expansion into select Walmart... 
Via Benzinga
Why Schrödinger Dived by Almost 12% Today
The company plunges sharply into the red on the bottom line in its Q3, and misses analyst estimates. 
Via The Motley Fool
BofA Downgrades Schrodinger On Slower Drug Discovery Ramp
Schrodinger Inc (NASDAQ:SDGR) reported downbeat third-quar... 
Via Benzinga
54 Stocks Moving In Thursday's Mid-Day Session
Gainers Pioneer Power Solutions, Inc. (NASDAQ: PPSI) shares gained 42.6% to $9.68. Pioneer Power Solutions recently announced the launch of its E-Boost portfolio of mobile... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 11, 2021
Upgrades Barrington Research upgraded the previous rating for Clear Channel Outdoor Holdings Inc (NYSE: 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers ADMA Biologics (NASDAQ:ADMA) shares moved upwards by 11.42% to $1.56 during Thursday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.